General Information
Revision date
2008-08-01
Product name
Phenomav 100 mg Anticonvulsant Tablets For Dogs
CAS No.
50-06-6
1.2.1 Relevant identified uses
For the treatment of seizures, convulsions, idiopathic epilepsy and status epilepticus in dogs
supplier name
Mavlab Pty Ltd
Icons in SDS
Company Information
company name
Mavlab Pty Ltd
Section 2
SECTION 2: Hazards identification
This product is not dangerous goods under the Australian Dangerous Goods Code but is classified as hazardous according to the classification criteria of NOHSC:1008(2004), Approved Criteria For Classifying Hazardous Substances and the National Code of Practice for the Preparation of Material Safety Data Sheets 2nd Edition [NOHSC:2011(2003)] Although this material could be classified as dangerous goods on the basis of its toxicity, the capacities of the packages in which the material is shipped are less than the minimum pack sizes that would result in this material being classified as dangerous goods.
Potential health effects
This material is presented in tablet form and it is therefore not expected to pose inhalational or dermal health hazards. However, if tablet integrity is compromised and dust is generated, both dermal and inhalational hazard could result. In this case all the following could apply
Hazard statements
R23 R24 R25 R43 R60 R61 Toxic by inhalation Toxic if in contact with skin Toxic if swallowed. May cause sensitization by skin contact. May impair fertility. May cause harm to the unborn child
Precautionary statements
S45 S36/37/39 S22 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). Wear suitable protective clothing, gloves, and eye/face protection. Do not breathe dust.